Julie Hviid Hahn-PedersenNovo Nordisk (Denmark)1 paperORCID 0000-0001-8187-7047 ↗OpenAlex ↗PapersValue in HealthIn silico·30 SepEstimating the Wider Societal Impact of Semaglutide Across Multiple Indications in Canada: an Economic Evaluation
Value in HealthIn silico·30 SepEstimating the Wider Societal Impact of Semaglutide Across Multiple Indications in Canada: an Economic Evaluation